Literature DB >> 23169445

Monitoring of ubiquitin-proteasome activity in living cells using a Degron (dgn)-destabilized green fluorescent protein (GFP)-based reporter protein.

Ruth Greussing1, Hermann Unterluggauer, Rafal Koziel, Andrea B Maier, Pidder Jansen-Dürr.   

Abstract

Proteasome is the main intracellular organelle involved in the proteolytic degradation of abnormal, misfolded, damaged or oxidized proteins (1, 2). Maintenance of proteasome activity was implicated in many key cellular processes, like cell's stress response (3), cell cycle regulation and cellular differentiation (4) or in immune system response (5). The dysfunction of the ubiquitin-proteasome system has been related to the development of tumors and neurodegenerative diseases (4, 6). Additionally, a decrease in proteasome activity was found as a feature of cellular senescence and organismal aging (7, 8, 9, 10). Here, we present a method to measure ubiquitin-proteasome activity in living cells using a GFP-dgn fusion protein. To be able to monitor ubiquitin-proteasome activity in living primary cells, complementary DNA constructs coding for a green fluorescent protein (GFP)-dgn fusion protein (GFP-dgn, unstable) and a variant carrying a frameshift mutation (GFP-dgnFS, stable (11)) are inserted in lentiviral expression vectors. We prefer this technique over traditional transfection techniques because it guarantees a very high transfection efficiency independent of the cell type or the age of the donor. The difference between fluorescence displayed by the GFP-dgnFS (stable) protein and the destabilized protein (GFP-dgn) in the absence or presence of proteasome inhibitor can be used to estimate ubiquitin-proteasome activity in each particular cell strain. These differences can be monitored by epifluorescence microscopy or can be measured by flow cytometry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23169445      PMCID: PMC3520582          DOI: 10.3791/3327

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  18 in total

Review 1.  Degradation of oxidized proteins by the 20S proteasome.

Authors:  K J Davies
Journal:  Biochimie       Date:  2001 Mar-Apr       Impact factor: 4.079

2.  Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.

Authors:  N P Dantuma; K Lindsten; R Glas; M Jellne; M G Masucci
Journal:  Nat Biotechnol       Date:  2000-05       Impact factor: 54.908

3.  Lack of proteasome active site allostery as revealed by subunit-specific inhibitors.

Authors:  J Myung; K B Kim; K Lindsten; N P Dantuma; C M Crews
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

4.  Age-dependent declines in proteasome activity in the heart.

Authors:  Anne-Laure Bulteau; Luke I Szweda; Bertrand Friguet
Journal:  Arch Biochem Biophys       Date:  2002-01-15       Impact factor: 4.013

5.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

Review 6.  Roles of the ubiquitin-proteosome system in neurogenesis.

Authors:  Tran Cong Tuoc; Anastassia Stoykova
Journal:  Cell Cycle       Date:  2010-08-15       Impact factor: 4.534

Review 7.  The ubiquitin-proteasome pathway and endothelial (dys)function.

Authors:  Karl Stangl; Verena Stangl
Journal:  Cardiovasc Res       Date:  2009-09-17       Impact factor: 10.787

8.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Authors:  K L Rock; C Gramm; L Rothstein; K Clark; R Stein; L Dick; D Hwang; A L Goldberg
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

9.  Functional interplay between mitochondrial and proteasome activity in skin aging.

Authors:  Rafał Kozieł; Ruth Greussing; Andrea B Maier; Lieve Declercq; Pidder Jansen-Dürr
Journal:  J Invest Dermatol       Date:  2010-12-30       Impact factor: 8.551

10.  A transgenic mouse model of the ubiquitin/proteasome system.

Authors:  Kristina Lindsten; Victoria Menéndez-Benito; Maria G Masucci; Nico P Dantuma
Journal:  Nat Biotechnol       Date:  2003-07-20       Impact factor: 54.908

View more
  5 in total

1.  Mode of targeting to the proteasome determines GFP fate.

Authors:  Christopher Eric Bragança; Daniel Adam Kraut
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

2.  A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy.

Authors:  Israel Hernandez; Gabriel Luna; Jennifer N Rauch; Surya A Reis; Michel Giroux; Celeste M Karch; Daniel Boctor; Youssef E Sibih; Nadia J Storm; Antonio Diaz; Susmita Kaushik; Cezary Zekanowski; Alexander A Kang; Cassidy R Hinman; Vesna Cerovac; Elmer Guzman; Honjun Zhou; Stephen J Haggarty; Alison M Goate; Steven K Fisher; Ana M Cuervo; Kenneth S Kosik
Journal:  Sci Transl Med       Date:  2019-03-27       Impact factor: 17.956

3.  Store-Operated Ca2+ Entry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism.

Authors:  Mate Maus; Mario Cuk; Bindi Patel; Jayson Lian; Mireille Ouimet; Ulrike Kaufmann; Jun Yang; Rita Horvath; Hue-Tran Hornig-Do; Zofia M Chrzanowska-Lightowlers; Kathryn J Moore; Ana Maria Cuervo; Stefan Feske
Journal:  Cell Metab       Date:  2017-01-26       Impact factor: 27.287

4.  Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis.

Authors:  Susmita Kaushik; Ana Maria Cuervo
Journal:  Nat Cell Biol       Date:  2015-05-11       Impact factor: 28.824

5.  A new model to investigate UVB-induced cellular senescence and pigmentation in melanocytes.

Authors:  Ines Martic; Sophia Wedel; Pidder Jansen-Dürr; Maria Cavinato
Journal:  Mech Ageing Dev       Date:  2020-07-29       Impact factor: 5.432

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.